Yoo Ga Young, Jeong Jin Yong, Lee June, Park Jae Hoo, Kang Jiwon
Department of Thoracic and Cardiovascular Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Thoracic and Cardiovascular Surgery, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si, Republic of Korea.
J Thorac Dis. 2025 Apr 30;17(4):2050-2055. doi: 10.21037/jtd-2024-2145. Epub 2025 Apr 21.
Compensatory hyperhidrosis (CH) is a frequent complication following sympathectomy, influencing patient satisfaction. This study was established to evaluate the impact of bilateral thoracoscopic sympathetic nerve block (TSNB) on patient satisfaction after sympathectomy in the treatment of primary hyperhidrosis.
From March 2021 to August 2023, 52 patients with primary palmar and craniofacial hyperhidrosis underwent TSNB at T3 using a 2-mm thoracoscope under local anesthesia. One week later, they decided whether to proceed with sympathectomy. Satisfaction was assessed using a 100-point scale, and patients were divided into two groups based on CH occurrence after sympathectomy. The groups were compared in terms of sex, age, hyperhidrosis site, and satisfaction scores.
Among 52 patients who underwent TSNB, 35 (67.31%) proceeded to sympathectomy, and CH occurred in 18 (51.43%) of these patients, while the remaining 17 patients (48.57%) did not develop CH. No significant differences were observed between the CH and no-CH groups regarding age (26.61±9.02 25.41±10.09 years, P=0.66), sex (61.11% 52.94% male, P=0.88), or primary hyperhidrosis site (palmar: 77.78% 88.24%, P=0.66). Satisfaction scores were comparable between the CH group (92.50±7.33) and the no-CH group (96.18±4.52), with no statistically significant difference (P=0.15).
Sympathectomy is associated with a high incidence of CH. Through TSNB, patients could preoperatively experience potential effects, including CH, enabling informed surgical decisions. Patients who developed CH reported high satisfaction levels comparable to those without CH, underscoring the utility of TSNB in improving patient-centered outcomes.
代偿性多汗症(CH)是交感神经切除术后常见的并发症,影响患者满意度。本研究旨在评估双侧胸腔镜交感神经阻滞(TSNB)对原发性多汗症患者交感神经切除术后患者满意度的影响。
2021年3月至2023年8月,52例原发性手掌和头面部多汗症患者在局部麻醉下使用2毫米胸腔镜在T3水平进行TSNB。一周后,他们决定是否进行交感神经切除术。使用100分制评估满意度,并根据交感神经切除术后CH的发生情况将患者分为两组。比较两组患者的性别、年龄、多汗症部位和满意度得分。
在接受TSNB的52例患者中,35例(67.31%)进行了交感神经切除术,其中18例(51.43%)发生了CH,其余17例(48.57%)未发生CH。CH组和无CH组在年龄(26.61±9.02岁对25.41±10.09岁,P=0.66)、性别(男性分别为61.11%对52.94%,P=0.88)或原发性多汗症部位(手掌:77.78%对88.24%,P=0.66)方面无显著差异。CH组(92.50±7.33)和无CH组(96.18±4.52)的满意度得分相当,无统计学显著差异(P=0.15)。
交感神经切除术与CH的高发生率相关。通过TSNB,患者可以在术前体验包括CH在内的潜在影响,从而做出明智的手术决策。发生CH的患者报告的满意度水平与未发生CH的患者相当,强调了TSNB在改善以患者为中心的结局方面的实用性。